Comparative thromboembolic risk and polypharmacy-related drug–drug interaction signals among antidiabetic medications: a large-scale FAERS pharmacovigilance study

BackgroundThe relationship between antidiabetic drugs and thromboembolic events remains unclear. The FDA Adverse Event Reporting System (FAERS) data was used to systematically assess safety signals and polypharmacy-related drug–drug interactions of antidiabetic medications.MethodsBy analyzing FAERS...

Full description

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: Duaa Bafail, Hany Ghazal
Format: Article
Language:English
Published: Frontiers Media S.A. 2026-05-01
Subjects:
antidiabetic drugs
disproportionality analysis
drug–drug interactions
FAERS database
pharmacovigilance
thromboembolic events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2026.1826021/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2026.1826021/full

Similar Items